Sartorius Aktiengesellschaft (SRT3) - Total Liabilities
Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT3) has total liabilities worth €5.60 Billion EUR (≈ $6.55 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Sartorius Aktiengesellschaft long-term investment allocation to see how much of total assets are deployed in long-term investments.
Sartorius Aktiengesellschaft - Total Liabilities Trend (2002–2025)
This chart illustrates how Sartorius Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Sartorius Aktiengesellschaft (SRT3) total assets.
Sartorius Aktiengesellschaft Competitors by Total Liabilities
The table below lists competitors of Sartorius Aktiengesellschaft ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RAKUTEN GROUP SPONS.ADR 1
F:RAKA
|
Germany | €27.45 Trillion |
|
Futu Holdings Limited
F:6FHA
|
Germany | €206.58 Billion |
|
Chocoladefabriken Lindt & Spruengli AG Part
SW:LISP
|
Switzerland | CHF3.81 Billion |
|
TATA CONSUMER PRODUCTS LIMITED
NSE:TATACONSUM
|
India | Rs103.02 Billion |
|
Align Technology Inc
NASDAQ:ALGN
|
USA | $2.16 Billion |
|
Klepierre SA
PA:LI
|
France | €10.70 Billion |
|
Ipsen SA
PA:IPN
|
France | €2.60 Billion |
|
Shenzhen Megmeet Electrical Co Ltd
SHE:002851
|
China | CN¥7.35 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Sartorius Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SRT3 equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.99 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sartorius Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sartorius Aktiengesellschaft (2002–2025)
The table below shows the annual total liabilities of Sartorius Aktiengesellschaft from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €5.85 Billion ≈ $6.84 Billion |
-5.73% |
| 2024-12-31 | €6.21 Billion ≈ $7.25 Billion |
-11.33% |
| 2023-12-31 | €7.00 Billion ≈ $8.18 Billion |
+62.03% |
| 2022-12-31 | €4.32 Billion ≈ $5.05 Billion |
+8.57% |
| 2021-12-31 | €3.98 Billion ≈ $4.65 Billion |
+20.72% |
| 2020-12-31 | €3.30 Billion ≈ $3.85 Billion |
+86.89% |
| 2019-12-31 | €1.76 Billion ≈ $2.06 Billion |
+13.49% |
| 2018-12-31 | €1.55 Billion ≈ $1.82 Billion |
+4.18% |
| 2017-12-31 | €1.49 Billion ≈ $1.74 Billion |
+46.74% |
| 2016-12-31 | €1.02 Billion ≈ $1.19 Billion |
+28.23% |
| 2015-12-31 | €792.48 Million ≈ $926.50 Million |
+2.21% |
| 2014-12-31 | €775.37 Million ≈ $906.49 Million |
+7.07% |
| 2013-12-31 | €724.14 Million ≈ $846.60 Million |
+8.54% |
| 2012-12-31 | €667.20 Million ≈ $780.02 Million |
+11.61% |
| 2011-12-31 | €597.82 Million ≈ $698.91 Million |
+24.40% |
| 2010-12-31 | €480.56 Million ≈ $561.83 Million |
-4.11% |
| 2009-12-31 | €501.18 Million ≈ $585.93 Million |
-5.73% |
| 2008-12-31 | €531.62 Million ≈ $621.52 Million |
+18.18% |
| 2007-12-31 | €449.84 Million ≈ $525.91 Million |
+115.84% |
| 2006-12-31 | €208.41 Million ≈ $243.65 Million |
-4.44% |
| 2005-12-31 | €218.09 Million ≈ $254.98 Million |
-1.06% |
| 2004-12-31 | €220.43 Million ≈ $257.71 Million |
-7.09% |
| 2003-12-31 | €237.26 Million ≈ $277.39 Million |
-10.21% |
| 2002-12-31 | €264.26 Million ≈ $308.94 Million |
-- |
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more